RaySearch Laboratories Management

Management Kriterienprüfungen 3/4

RaySearch Laboratories' CEO ist Johan Lof , ernannt in Jan 2000, hat eine Amtszeit von 24.42 Jahren. Die jährliche Gesamtvergütung beträgt SEK9.76M , bestehend aus 66.2% Gehalt und 33.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 16.51% der Aktien des Unternehmens, im Wert von SEK816.39M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.7 Jahre bzw. 20.8 Jahre.

Wichtige Informationen

Johan Lof

Geschäftsführender

kr9.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	66.2%
Amtszeit als Geschäftsführer	24.4yrs
Eigentum des Geschäftsführers	16.5%
Durchschnittliche Amtszeit des Managements	5.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	20.8yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Johan Lof im Vergleich zu den Einnahmen von RaySearch Laboratories verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	kr101m
Dec 31 2023	kr10m	kr6m	kr82m
Sep 30 2023	n/a	n/a	kr64m
Jun 30 2023	n/a	n/a	kr53m
Mar 31 2023	n/a	n/a	kr22m
Dec 31 2022	kr7m	kr6m	kr24m
Sep 30 2022	n/a	n/a	-kr6m
Jun 30 2022	n/a	n/a	-kr38m
Mar 31 2022	n/a	n/a	-kr35m
Dec 31 2021	kr7m	kr6m	-kr47m
Sep 30 2021	n/a	n/a	-kr46m
Jun 30 2021	n/a	n/a	-kr50m
Mar 31 2021	n/a	n/a	-kr42m
Dec 31 2020	kr7m	kr6m	-kr9m
Sep 30 2020	n/a	n/a	kr24m
Jun 30 2020	n/a	n/a	kr43m
Mar 31 2020	n/a	n/a	kr74m
Dec 31 2019	kr8m	kr6m	kr50m
Sep 30 2019	n/a	n/a	kr64m
Jun 30 2019	n/a	n/a	kr85m
Mar 31 2019	n/a	n/a	kr84m
Dec 31 2018	kr8m	kr5m	kr79m
Sep 30 2018	n/a	n/a	kr118m
Jun 30 2018	n/a	n/a	kr104m
Mar 31 2018	n/a	n/a	kr103m
Dec 31 2017	kr9m	kr5m	kr118m

Vergütung im Vergleich zum Markt: JohanDie Gesamtvergütung ($USD928.02K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt UK ($USD988.38K).

Entschädigung vs. Einkommen: JohanDie Bezüge der Mitarbeiter sind im vergangenen Jahr um mehr als 20 % gestiegen.

Geschäftsführer

Johan Lof (55 yo)

24.4yrs

Amtszeit

kr9,758,000

Vergütung

Dr. Johan Lof has been the Chief Executive Officer and President of Raysearch Laboratories AB (Publ) since 2000. Dr. Lof serves as the Chief Executive Officer of RaySearch Medical AB. Dr. Lof has been a Di...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Johan Lof	Founder	24.4yrs	kr9.76m	16.51% SEK 816.4m
Bjorn Hardemark	Deputy Chief Executive Officer	8.8yrs	kr3.54m	0.052% SEK 2.6m
Annika Henriksson	Deputy Chief Financial Officer	less than a year	keine Daten	keine Daten
Kjell Eriksson	Head of Research & Chief Science Officer	8.8yrs	keine Daten	0.070% SEK 3.5m
Petra Jansson	General Counsel	6.9yrs	keine Daten	keine Daten
Peter Kemlin	Director of Sales & Marketing	no data	keine Daten	0.0041% SEK 201.7k
Tove Alteborg	Global Human Resource Manager	less than a year	keine Daten	keine Daten
Fredrik Lofman	Head of Machine Learning	4.4yrs	keine Daten	0.0041% SEK 201.7k
Marc Mlyn	President & CEO of RaySearch Americas	2.4yrs	keine Daten	keine Daten

5.7yrs

Durchschnittliche Betriebszugehörigkeit

50.5yo

Durchschnittliches Alter

Erfahrenes Management: 0GRZDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.7 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Johan Lof	Founder	24.4yrs	kr9.76m	16.51% SEK 816.4m
Hans Wigzell	Independent Chairman of Board	20.1yrs	kr840.00k	keine Daten
Carl Bergendal	Independent Director	24.4yrs	kr225.00k	3.39% SEK 167.5m
Radhe Mohan	Member of Scientific Advisory Board	21.4yrs	keine Daten	keine Daten
Anders Forsgren	Member of Scientific Advisory Board	no data	keine Daten	keine Daten
Anders Brahme	Member of Scientific Advisory Board	no data	keine Daten	3.79% SEK 187.5m
David Jaffray	Member of Scientific Advisory Board	no data	keine Daten	keine Daten
Britta Wallgren	Independent Director	6.1yrs	kr300.00k	0.020% SEK 1.0m
Gunther Marder	Independent Director	1.6yrs	kr300.00k	0.20% SEK 10.1m

20.8yrs

Durchschnittliche Betriebszugehörigkeit

70yo

Durchschnittliches Alter

Erfahrener Vorstand: 0GRZDie Vorstandsmitglieder sind sehr erfahren ( 20.8 ).

RaySearch Laboratories Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Henrik Bergentoft Leaves the Position as CFO for Raysearch

Founder recently sold kr40m worth of stock

Director recently bought kr88k worth of stock

Founder recently sold kr1.1m worth of stock

High number of new directors

Raysearch Laboratories AB (Publ) Elects Günther Mårder as New Board Member

Recent updates

RaySearch Laboratories AB (publ) Releases RayCare 2024A

Now 21% undervalued

Raysearch Laboratories AB (Publ) Apprves Ordinary Dividend for the Year 2023

First quarter 2024 earnings released: EPS: kr1.07 (vs kr0.51 in 1Q 2023)

Upcoming dividend of kr2.00 per share

Raysearch to Present the Latest Advances in Raystation, Raycare and Rayintelligence At Estro 2024

Investor sentiment improves as stock rises 18%

Full year 2023 earnings released: EPS: kr2.38 (vs kr0.69 in FY 2022)

New major risk - Revenue and earnings growth

RaySearch Laboratories AB (publ) Proposes an Extra Dividend for the Year Ended December 31, 2023, Payable on May 29, 2024

RaySearch Laboratories AB (publ) to Report Fiscal Year 2024 Results on Feb 14, 2025

RaySearch Laboratories AB (publ) Releases Raystation 2024A

Third quarter 2023 earnings released: EPS: kr0.63 (vs kr0.29 in 3Q 2022)

RaySearch Laboratories AB (publ) to Report Q2, 2024 Results on Aug 16, 2024

RaySearch to Showcase Latest Innovations in Raystation, RayCare and RayIntelligence to Be Presented at ASTRO 2023

RaySearch Laboratories AB (Publ) to Showcase the Latest Software Innovations At Astro in San Diego, California, October 1-4

RaySearch Laboratories AB (publ) to Report Fiscal Year 2023 Results on Feb 23, 2024

RaySearch Laboratories AB (publ) to Report Q1, 2024 Results on May 17, 2024

Second quarter 2023 earnings released

RaySearch to Present the Latest Advances in Raystation, RayCare and RayIntelligence at AAPM 2023

RaySearch Laboratories AB (Publ) Announces the Release of the Latest Version of RayCare®, the Next Generation Oncology Information System

RaySearch Laboratories AB (publ) Releases Raystation 2023B

Raysearch Laboratories AB (Publ)'s RayCare in clinical use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland

Henrik Bergentoft Leaves the Position as CFO for Raysearch

Founder recently sold kr40m worth of stock

New minor risk - Shareholder dilution

RaySearch Laboratories AB (publ) Announce to Exhibit Latest Software Innovations for Particle Therapy and BNCT at PTCOG 2023

First quarter 2023 earnings released

Director recently bought kr88k worth of stock

Founder recently sold kr1.1m worth of stock

Full year 2022 earnings released: EPS: kr0.69 (vs kr1.38 loss in FY 2021)

RaySearch Laboratories AB (publ) to Report Fiscal Year 2022 Results on Feb 28, 2023

RaySearch Laboratories AB (publ) to Report Q3, 2023 Results on Nov 17, 2023

Third quarter 2022 earnings released

High number of new directors

Raysearch Laboratories AB (Publ) Elects Günther Mårder as New Board Member

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Second quarter 2022 earnings released

Now 29% undervalued after recent price drop

Raysearch Laboratories AB (Publ) Appoints Henrik Bergentoft as Cfo, Effective from November 15, 2022

RaySearch Laboratories AB (publ) Launches RayStation 12A

RaySearch to Exhibit the Latest Software Innovations for Particle Therapy at PTCOG 2022

RaySearch Laboratories AB (publ) Releases Latest Version of RayCare

Founder recently sold kr20m worth of stock

First quarter 2022 earnings released

Raysearch Laboratories AB (Publ) Announces Raystation, Rayintelligence and Raycare to Be Presented At Estro 2022

Insufficient new directors

RaySearch Laboratories AB (publ) Announces Executive Changes

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Founder recently sold kr5.6m worth of stock

RaySearch AB (publ) Provides Cancer Clinics with User Configurable Workflows for Radiation Therapy

RayStation 11B Brings New Features for Adaptive Workflows, Brachytherapy, and Radiation Therapy with Ions

Third quarter 2021 earnings released

RaySearch Laboratories AB (publ) to Showcase Latest Innovations, RayIntelligence and RayCare at ESTRO 2021

Second quarter 2021 earnings released

Insufficient new directors

RaySearch Laboratories AB (Publ) Announces RayStation 9 Granted Regulatory Clearance in China

Raysearch Announces the Release of A New Version of Raycare®, the Next-Generation Oncology Information System

Raysearch Laboratories Announces the Release of Raystation® 11A

Raysearch Laboratories AB (Publ) Provides Earnings Guidance for 2021

RaySearch Laboratories AB (publ) Announces Royal Brisbane and Women's Hospital Treats First Patients Using the Raystation® Treatment Planning System

New 90-day high: kr93.60

Full year 2020 earnings released: kr0.26 loss per share (vs kr1.47 profit in FY 2019)

Revenue misses expectations

RaySearch Laboratories AB (publ) to Report First Half, 2021 Results on Aug 25, 2021

RaySearch Laboratories AB (publ) Announces University Medical Center Maribor in Slovenia Became the 700th Customer to Select RayStation

New 90-day high: kr91.55

RaySearch Receives New Order from Centre Antoine Lacassagne for RayStation in France